本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Prevail Therapeutics

23.00
+0.0000
成交量:- -
成交額:- -
市值:1.58億
市盈率:-9.96
高:23.00
開:23.00
低:23.00
收:23.00
資料載入中...
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/22

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/01/22

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/01/22

重要事件披露

8-K - Current report
2021/01/22

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/12/22

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/12/15

重要事件披露

8-K - Current report
2020/11/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/13

重要事件披露

8-K - Current report
2020/11/12

重要事件披露

8-K - Current report
2020/11/02

重要事件披露

8-K - Current report
2020/10/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/10

重要事件披露

8-K - Current report
2020/08/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/11

重要事件披露

8-K - Current report